-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
- Outlook Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was -$3.18 K, a 100% decline year-over-year.
- Outlook Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $49 M, a 17.8% decline from 2022.
- Outlook Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $59.6 M, a 6.05% increase from 2021.
- Outlook Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $56.2 M, a 51% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)